Oral deferiprone for iron chelation in people with thalassaemia-Reference-Cited by-同舟云学术

Oral deferiprone for iron chelation in people with thalassaemia

Published:2013-08-21 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Fisher Sheila A¹,Brunskill Susan J¹,Doree Carolyn¹,Chowdhury Onima²,Gooding Sarah³,Roberts David J¹

Affiliation:

1. NHS Blood and Transplant; Systematic Review Initiative; Level 2, John Radcliffe Hospital Headington Oxford Oxon UK OX3 9BQ

2. Weatherall Institute of Molecular Medicine; Haematopoietic Stem Cell Laboratory; John Radcliffe and Churchill Hospital Oxford UK OX3 9DS

3. John Radcliffe and Churchill Hospital; Department of Haematology; Old Road Oxford UK OX3 7LJ

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004839.pub3/fullpdf

Reference171 articles.

1. Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience;Abdelrazik;Hematology,2007

2. Pattern of iron chelation therapy in Egyptian children with beta-thalassaemia: one-year Mansoura University Childrens Hospital experience [abstract];Abdelrazik;Haematologica,2007

3. Randomised, prospective evaluation of iron balance, chelation efficiency, urine excretion and NTBI progression with deferiprone (DFP) or deferoxamine (DFO) monotherapy or with combined DFP plus DFO [abstract];Aydinok;Blood,2005

4. A randomized controlled trial comparing the combination therapy of deferiprone (DFP) and Desferrioxamine (DFO) versus DFP or DFO monotherapy in patients with thalassaemia major [abstract];Aydinok;Blood,2006

5. A randomized, controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassaemia major;Aydinok;Haematologica,2007

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing Thalassaemia Management from Patients’ Perspectives: An International Collaborative Assessment;Medicina;2024-04-18

2. Whistleblower’s decades long fight to save patients from dangerous research;BMJ;2024-03-06

3. Challenges of Iron Chelation in Thalassemic Children;Thalassemia Reports;2024-02-01

4. Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases;Journal of Zhejiang University-SCIENCE B;2024-01

5. Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East;Blood Reviews;2024-01